CALL FOR PAPERS
Submit to this PLOS ONE call for papers to help expand the global knowledge on influenza. Submission deadline, April 09, 2021.
This call for papers is closed.
Influenza is an important cause of death and morbidity globally. While vaccination is the best way to prevent influenza virus infection, other pharmaceutical and non-pharmaceutical strategies can prevent or mitigate the impact of influenza on individuals and the spread within populations. Influenza viruses are continually evolving, posing challenges to vaccination strategies and vaccine development.
This PLOS ONE call for papers aims to create a collection of research articles that focuses on influenza prevention on every level. We welcome submissions reporting in vitro, translational, and clinical studies; disease and immunity modelling; as well as new approaches to influenza prevention.
Dr. Deshayne Fell
University of Ottawa
Dr. Meagan Deming
University of Maryland Medical Center
United States of America
PLOS ONE is in the top 5 publishers for Influenza research.
Citations of PLOS ONE Influenza papers
Average citations for Influenza per year
Average days to first decision for related PLOS ONE Papers
PLOS ONE publishes primary research across all areas of science, including interdisciplinary research. Research articles are selected for scientific rigor rather than perceived impact.
Email questions to ONEcalls@plos.org.
Submit your paper to PLOS ONE to be considered for this Collection.
Mention the Influenza Call for Papers in your cover letter. The Collection will publish July 2021.